StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (OPHI) income statement

OPHINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as CLGN
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.40−0.20 (-5.56%)

Close on Nov 18, 2026Market cap $4.91MP/E –Yield –

CollPlant Biotechnologies Ltd income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
64.8%
Operating margin
-484.3%
Net margin
-484.6%
Return on equity, FY2025
-117.6%

Financial strength

Current ratio
1.57
Debt to equity
–
Debt to assets
–
Cash to current liabilities
102.9%

Valuation

P/E ratio
–
Price to sales
2.07
Price to book
1.67
Dividend yield
–

See a number that looks wrong?